Fujifilm Healthcare Americas Corporation
Fujifilm Healthcare Americas Corporation manufactures and supports diagnostic imaging equipment, endoscopy systems, and the Synapse enterprise imaging informatics platform for hospitals, health systems, imaging centers, clinical laboratories, and government customers across the United States and Canada.
- Company typePrivate
- Founded1936
- HeadquartersLexington, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Fujifilm Healthcare Americas Corporation does
Fujifilm Healthcare Americas Corporation is a wholly-owned U.S. subsidiary of Fujifilm Holdings Corporation (TSE: 4901), headquartered in Lexington, Massachusetts, that manufactures and integrates medical imaging hardware, endoscopy systems, surgical imaging, and enterprise imaging informatics software for the North American market. Its healthcare business traces to 1936 with x-ray film, and the current portfolio spans the full continuum from prevention to diagnosis and treatment. The company employs 501-1,000 people and distributes primarily through an enterprise field sales force with additional reach via the National Rural Health Association Platinum Partnership and exclusive U.S. Department of Defense contracts.
The core technology platform is Synapse, a comprehensive enterprise imaging suite comprising PACS modules for radiology, cardiology, and pathology, a Vendor Neutral Archive that has earned Best in KLAS for five consecutive years, an AI Orchestrator and Worklist Orchestrator for deploying AI applications across imaging workflows, and cloud services delivered in collaboration with AWS. The diagnostic imaging hardware portfolio includes MRI systems (Echelon Synergy 1.5T, OASIS Velocity, APERTO Lucent 0.4T open), CT (FCT iStream 128-slice, Scenaria View), digital radiography (FDR D-EVO detectors, FDR Go PLUS portable, FDR-Flex), mammography (ASPIRE Cristalle with DBT), ultrasound (ARIETTA series integrated with Brainlab surgical navigation), and surgical C-arms. The endoscopy division features the ELUXEO 8000 system with proprietary Multi-LED illumination and Amber-Red Color Imaging, the EB-710US balloon-less EBUS bronchoscope, double balloon enteroscopy (EN-840T), and AI-powered CAD EYE and SCALE EYE detection and measurement tools. The in vitro diagnostics business sells the μTASWako i30 immunoanalyzer and HCC risk biomarker tests AFP-L3 and DCP, both CMS-reimbursed via CPT 82107 and 83951.
The business model combines one-time capital hardware sales (MRI, CT, DR, mammography, C-arms), recurring Synapse subscription and cloud licensing, IVD reagent pull-through via clinical reference laboratories, and managed service contracts offering a 99% uptime guarantee. Customers span multi-state enterprise health systems (Ardent Health across six states, Hackensack Meridian Health, Adventist Health White Memorial), rural and critical access hospitals, outpatient imaging centers, veterinary practices, U.S. Army/Navy/DLA government contracts, and reference laboratories. Recent strategic activity includes the Inspirata digital pathology asset acquisition, the Ardent Health and KARL STORZ partnerships, AWS cloud collaboration, and a 2026 infrastructure expansion via a new 18,000-square-foot Fairfield, NJ warehouse and 1.5x expansion of the Wayne, NJ endoscopy service center. Revenue is not separately disclosed at the subsidiary level.
Fujifilm Healthcare Americas Corporation firmographics
Firmographics- Name
- Fujifilm Healthcare Americas Corporation
- Legal name
- FUJIFILM Healthcare Americas Corporation
- Website
- https://healthcaresolutions-us.fujifilm.com
- Company type
- Private
- Founded year
- 1936
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Fujifilm Healthcare Americas Corporation manufactures and supports diagnostic imaging equipment, endoscopy systems, and the Synapse enterprise imaging informatics platform for hospitals, health systems, imaging centers, clinical laboratories, and government customers across the United States and Canada.
- Ownership category
- akta.pro rank
Fujifilm Healthcare Americas Corporation industry classification
Industry- Product category
- Medical Imaging Equipment
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Irradiation Apparatus Manufacturing (334517), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Imaging Informatics & Workflow (PACS/RIS/VNA) (HLAHABAI)
- akta.pro secondary industries
- X-ray & Fluoroscopy Systems (HLAHABAA), Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD), Teleradiology Platforms & Reading Workflow (HLACALAK), Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE) (HLACALAJ), Radiology Reporting, Dictation & Structured Reporting (HLACALAF), Imaging Equipment & Accessories (X-ray, Ultrasound, Endoscopy) (HLAMAFAC)
Keywords
Where Fujifilm Healthcare Americas Corporation is headquartered
LocationHeadquarters
- HQ city
- Lexington
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Fujifilm Healthcare Americas Corporation business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Medical Imaging Hardware: Sale of diagnostic imaging equipment including MRI systems, CT scanners, digital radiography (DR) detectors and rooms, ultrasound systems, endoscopic imaging systems, surgical C-arms, and mammography systems. Hardware sales are one-time capital purchases with associated service contracts.
- Enterprise Imaging Software (Synapse): Subscription and licensing of the Synapse enterprise imaging platform (PACS, VNA, AI Orchestrator, analytics, cloud services) to health systems and hospitals. Software provides recurring revenue through licenses, subscriptions, and cloud service fees.
- In Vitro Diagnostics (IVD) Reagents and Systems: Sale of clinical diagnostic reagents (AFP-L3, DCP, complement activity, cholesterol tests, etc.) and the μTASWako i30 immunoanalyzer to clinical laboratories. Both AFP-L3 and DCP tests are CMS-reimbursed in the United States via CPT codes 82107 and 83951 respectively.
- Service and Support Contracts: Comprehensive service and support offerings including installation, rigging, applications training, remote service (with 99% uptime guarantee), on-site service, replacement parts, site accreditation support, and technical support for diagnostic imaging, endoscopy, enterprise imaging, and IVD products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | IVD biomarker tests (AFP-L3 and DCP) are available at major reference laboratories in the United States and are CMS-reimbursed. No public list pricing disclosed. |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
Fujifilm Healthcare Americas Corporation product offering
Product offeringCore offering
Fujifilm Healthcare Americas Corporation manufactures and sells diagnostic medical imaging equipment (MRI, CT, digital radiography, ultrasound, mammography, surgical C-arms), endoscopic imaging systems (ELUXEO platform), the Synapse enterprise imaging software platform (PACS, VNA, AI orchestration), in vitro diagnostic biomarker tests (AFP-L3, DCP) run on the μTASWako i30 immunoanalyzer, and Vincent surgical planning tools. The company serves hospitals, health systems, imaging centers, clinical laboratories, and government/defense customers across North America.
Product overview
Fujifilm Healthcare Americas Corporation offers a comprehensive healthcare portfolio built around a platform-plus-modules architecture. The core Synapse Enterprise Imaging platform serves as the foundation, with specialized PACS modules for radiology (Synapse Radiology PACS), cardiology (Synapse Cardiology PACS), and pathology (Synapse Pathology), augmented by VNA, cloud services, and AI orchestration tools including Synapse AI Orchestrator and Synapse Worklist Orchestrator. The diagnostic imaging portfolio spans multiple modalities: digital radiography (FDR D-EVO detectors, FDR Go PLUS portable systems), MRI (Echelon Synergy, OASIS Velocity, APERTO Lucent), CT (FCT iStream, Scenaria View), mammography (ASPIRE Cristalle), surgical C-arms (FDR Cross), and ultrasound (ARIETTA series). The endoscopy division provides endoscopic imaging systems (ELUXEO 8000, ELUXEO Vision), bronchoscopy (EB-710US EBUS), double balloon enteroscopy (EN-840T), and AI-powered detection tools (CAD EYE, SCALE EYE). In vitro diagnostics includes HCC risk biomarkers (AFP-L3, DCP) and the μTASWako i30 immunoanalyzer. Surgical imaging solutions include Vincent surgical planning for hepatobiliary, lung, and urology procedures. The company supports customers from prevention through diagnosis and treatment across the patient care continuum.
Differentiator
Problem solved
Functional benefit
Brands
- Synapse: Enterprise imaging platform including PACS, VNA, and related imaging informatics solutions
- ELUXEO
- CAD EYE
- SCALE EYE
- FDR
- ASPIRE Cristalle
- ARIETTA
- μTASWako
- APERTO Lucent
- Echelon Synergy
- FCT iStream
- Vincent
Products and services
- Synapse Enterprise PACS Comprehensive Picture Archiving and Communication System platform providing enterprise imaging informatics for radiology, cardiology, and pathology imaging data management across healthcare enterprises.
- Synapse VNA Vendor Neutral Archive component of the Synapse platform providing centralized storage and access to imaging data across multiple departments and modalities with interoperability for various healthcare systems.
- Synapse AI Orchestrator AI workflow orchestration platform enabling healthcare organizations to deploy and maintain AI applications for clinical workflows across enterprise imaging systems including radiology, cardiology, and pathology.
- Synapse Worklist Orchestrator AI-powered worklist automation tool designed to streamline imaging workflows, improve radiologist efficiency, and address staffing shortages and burnout through intelligent work distribution.
- Synapse Pathology Digital pathology PACS system integrating with mTuitive's structured pathology reporting platform, creating unified diagnostic workflows connecting pathology and enterprise imaging with CAP and Commission on Cancer compliant synoptic data.
- Synapse One Comprehensive enterprise imaging and informatics solution tailored for outpatient imaging centers, providing a complete workflow solution designed for the specific demands and workflows of outpatient imaging facilities.
- Synapse Cloud Services Cloud-based enterprise imaging services providing scalable storage, accessibility, and management of imaging data with cloud-native architecture.
- ELUXEO 8000 Endoscopic Imaging System Next-generation endoscopic imaging system with 4K resolution, Multi-LED illumination technology, and proprietary Amber-Red Color Imaging mode for enhanced polyp detection, third space endoscopy, and submucosal visualization.
- ELUXEO Vision Endoscopic imaging system designed for endoluminal surgery procedures, featuring advanced visualization capabilities for surgical endoscopy applications.
- EB-710US Balloon-less EBUS Bronchoscope Novel balloon-less endobronchial ultrasound (EBUS) bronchoscope for pulmonary care that eliminates the need for traditional balloons, reducing infection risks, preparation time, and disposable costs while offering improved maneuverability with 6.4mm distal end and 180-degree angulation.
- EN-840T Double Balloon Enteroscopy Scope Double balloon enteroscopy scope for diagnosis and treatment in the small intestine; winner of the 2025 MedTech Breakthrough Award for Best Medical Device Solution.
- ARIETTA Ultrasound Systems Line of ultrasound diagnostic systems including ARIETTA 650, ARIETTA 750, ARIETTA 850, and ARIETTA Precision models for cardiovascular, general imaging, and surgical guidance applications, integrated with Brainlab surgical navigation for neurosurgical use.
- CAD EYE AI-powered detection system for colonoscopy that uses computer vision to identify colonic polyps in real-time during endoscopic procedures, designed to improve adenoma detection rates (ADR). Clinical studies showed CAD EYE plus LTI increased ADR from 38% to nearly 50%.
- FDR D-EVO III Detector Digital radiography detector with advanced image processing capabilities for high-quality X-ray imaging in various clinical settings.
- FDR Go PLUS Portable DR System Mobile digital radiography system providing portable X-ray capabilities for bedside imaging, emergency departments, intensive care units, and athletic/sports medicine applications.
- FCT iStream CT System 128-slice computed tomography system with AI-enabled features and Vision Modeling Iterative Reconstruction, capable of capturing up to 60 images per second.
- Echelon Synergy MRI System 1.5T MRI system with AI-powered workflow enhancements and deep learning reconstruction technology for improved imaging quality and efficiency.
- OASIS Velocity Open MRI Open MRI system designed to accommodate patients who may experience claustrophobia in traditional closed-bore MRI systems.
- APERTO Lucent Open MRI 0.4T open MRI system designed for patient comfort with wide-open configuration, suitable for bariatric and claustrophobic patients as well as various clinical imaging applications.
- ASPIRE Cristalle Mammography System Digital breast tomosynthesis (DBT) mammography system with patented Comfort Paddle technology designed for patient comfort and high-quality breast cancer screening.
- FDR Cross C-Arm Two-in-one fluoroscopy and digital radiography system combining surgical imaging capabilities in a single device for intraoperative imaging.
- AFP-L3 Test HCC risk biomarker test measuring lectin-reactive alpha-fetoprotein (AFP-L3) as an aid in risk assessment for hepatocellular carcinoma development in chronic liver disease patients; CMS-reimbursed via CPT code 82107.
- DCP Test Des-gamma-carboxy prothrombin (DCP) serum biomarker test for HCC risk assessment, used in conjunction with AFP-L3 for early detection of hepatocellular carcinoma; CMS-reimbursed via CPT code 83951.
- μTASWako i30 Immunoanalyzer Fully automated microfluidic-based clinical immunoanalyzer for in vitro diagnostic use, providing parallel measurements for AFP-L3 and DCP biomarkers on a single platform.
- Vincent Surgical Planning Surgical planning solution for hepato-biliary pancreatic surgery, lung surgery, and urology procedures, providing pre-surgical visualization and planning capabilities.
Quantifiable outcome
- CAD EYE plus LTI increased adenoma detection rate (ADR) from 38% to nearly 50%, representing an 11% absolute increase and approximately 30% relative risk reduction for colorectal cancer development (University of Montreal Medical Center study).
- +3 more outcomes
Companies that use Fujifilm Healthcare Americas Corporation
Customer profileNamed customers16 records
Segments4 records
Ideal customer profiles5 records
Fujifilm Healthcare Americas Corporation technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability11 records
Feature15 records
Fujifilm Healthcare Americas Corporation partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- mTuitivecoreStrategic partnership to integrate mTuitive's structured pathology reporting platform with Fujifilm's Synapse Pathology PACS system, creating a unified diagnostic workflow connecting pathology and enterprise imaging. The integration automatically flows structured pathology reports including CAP and Commission on Cancer compliant synoptic data from mTuitive through the Laboratory Information System into Synapse, eliminating duplicative data entry and enabling real-time collaboration among radiologists, oncologists, and pathologists. The combined platform supports cancer registries, clinical analytics, research, and AI applications.
- Ardent HealthcorePartnership to deploy Synapse enterprise imaging solutions across Ardent Health's acute care hospital network spanning six states in the U.S. The unified diagnostic platform consolidates radiology and cardiology imaging data into a single viewer integrated with Epic's electronic health record system. The partnership aims to streamline clinical workflows, reduce administrative burden on physicians, and improve care coordination through AI-powered automation and faster result turnaround times.
- BrainlabcorePartnership between Brainlab SE and FUJIFILM Healare Americas Corporation to integrate Brainlab's surgical navigation platform with Fujifilm's ARIETTA Precision ultrasound system for enhanced neurosurgical imaging solutions. The integration combines Brainlab's surgical navigation capabilities with Fujifilm's ultrasound imaging technology.
- KARL STORZcoreStrategic collaboration between KARL STORZ and Fujifilm Healthcare Americas Corporation to deliver integrated endoscopy and surgery solutions. The partnership exemplifies how key players are pursuing partnerships to strengthen competitive positioning amid market expansion in flexible endoscopes and surgical imaging.
- EndoSimminorFujifilm Healthcare Americas transferred exclusive U.S. distributorship of its EndoGel endoscopy training model to EndoSim in February 2025. This partnership expands access to advanced endoscopy training by leveraging EndoSim's distribution capabilities.
- National Rural Health Association (NRHA)coreFujifilm Healthcare Americas was selected as a Platinum Partner by the NRHA for a second consecutive 3-year term. The partnership aims to improve access to medical imaging in rural communities by providing rural hospitals with advanced imaging systems, low capital impact purchasing plans, and custom marketing programs to help keep healthcare services local. The partnership is showcased at the NRHA Annual Conference.
- Amazon Web Services (AWS)coreStrategic collaboration agreement between Fujifilm and Amazon Web Services. Fujifilm has also partnered with AWS alongside a large East Coast health system to transform pathology delivery and diagnosis using cloud-native infrastructure.
- Hackensack Meridian HealthcoreExpanded partnership enabling network-wide use of state-of-the-art Synapse Cardiology PACS imaging system across Hackensack Meridian Health facilities.
- Helio HealthminorCollaboration to advance blood-based screening methods for early-stage liver cancer, combining Helio Health's liquid biopsy technology with Fujifilm's imaging and biomarker expertise.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Fujifilm Healthcare Americas Corporation competitors and assessment
Company assessmentBroad incumbents
- GE HealthCare: GE HealthCare is the largest medical imaging and ultrasound company globally, offering MRI, CT, X-ray, ultrasound, and enterprise imaging software. It is Fujifilm's broadest incumbent competitor across hardware and imaging IT.
- Siemens Healthineers: Siemens Healthineers provides MRI, CT, angiography, ultrasound, and the teamplay digital health platform. It directly competes with Fujifilm across imaging hardware and enterprise imaging IT.
- Philips (Royal Philips): Philips Health Systems offers MRI, CT, ultrasound, and a broad enterprise imaging informatics portfolio including IntelliSpace PACS. It is one of the most direct full-suite competitors to Synapse and Fujifilm's hardware lineup.
Direct peers
- Canon Medical Systems: Canon Medical Systems manufactures CT, MRI, X-ray, ultrasound, and angiography equipment and competes head-to-head with Fujifilm's imaging hardware portfolio, particularly in mid-tier hospitals and imaging centers.
- Hologic: Hologic is a leader in women's health imaging, particularly 3D mammography (3Dimensions system), directly competing with Fujifilm's ASPIRE Cristalle DBT mammography platform.
- Carestream Health: Carestream is a major competitor in digital radiography (DR) detectors and workflow solutions. Its DR and mobile X-ray systems overlap with Fujifilm's FDR product line in hospitals and imaging centers.
- Agfa HealthCare (Agfa-Gevaert): Agfa HealthCare provides enterprise imaging (PACS, VNA, imaging informatics) through its Enterprise Imaging Platform, directly competing with Fujifilm's Synapse suite in mid-market and large hospitals.
- Sectra: Sectra is a leading European enterprise imaging vendor specializing in PACS, VNA, and digital pathology. Its pathology push closely parallels Fujifilm's Synapse Pathology strategy, making it a niche direct competitor.
- Intelerad Medical Systems: Intelerad provides cloud-native PACS, VNA, and enterprise imaging solutions, competing primarily in mid-market hospitals and radiology groups. It is an emerging alternative to Synapse for cloud-first imaging deployments.
- Olympus Medical: Olympus is the global leader in flexible endoscopy and competes directly with Fujifilm's ELUXEO platform in gastroenterology and pulmonary endoscopy markets.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Fujifilm Healthcare Americas Corporation social profiles
Digital presenceFujifilm Healthcare Americas Corporation financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fujifilm Healthcare Americas Corporation leadership team
Management profileNumber of profiles
Profiles1 record
Fujifilm Healthcare Americas Corporation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fujifilm Healthcare Americas Corporation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fujifilm Healthcare Americas Corporation
What does Fujifilm Healthcare Americas Corporation do?
Fujifilm Healthcare Americas Corporation manufactures and sells diagnostic medical imaging equipment (MRI, CT, digital radiography, ultrasound, mammography, surgical C-arms), endoscopic imaging systems (ELUXEO platform), the Synapse enterprise imaging software platform (PACS, VNA, AI orchestration), in vitro diagnostic biomarker tests (AFP-L3, DCP) run on the μTASWako i30 immunoanalyzer, and Vincent surgical planning tools. The company serves hospitals, health systems, imaging centers, clinical laboratories, and government/defense customers across North America.
Is Fujifilm Healthcare Americas Corporation a public or private company?
Fujifilm Healthcare Americas Corporation is a private company. It is classified as corporate owned and is currently operating.
When was Fujifilm Healthcare Americas Corporation founded?
Fujifilm Healthcare Americas Corporation was founded in 1936. It employs 1,001 to 5,000 people.
Where is Fujifilm Healthcare Americas Corporation based?
Fujifilm Healthcare Americas Corporation is headquartered in Lexington, United States, in the North America region.
How does Fujifilm Healthcare Americas Corporation make money?
Four revenue lines are on record. Medical Imaging Hardware is the primary driver. The others are enterprise Imaging Software (Synapse), in Vitro Diagnostics (IVD) Reagents and Systems and service and Support Contracts.
Who are Fujifilm Healthcare Americas Corporation's main competitors?
Broad incumbents on record are GE HealthCare, Siemens Healthineers and Philips (Royal Philips). Direct peers are Canon Medical Systems, Hologic, Carestream Health, Agfa HealthCare (Agfa-Gevaert), Sectra, Intelerad Medical Systems and Olympus Medical.
Does Fujifilm Healthcare Americas Corporation have an API?
No public API is recorded for Fujifilm Healthcare Americas Corporation.
What industry is Fujifilm Healthcare Americas Corporation in?
Fujifilm Healthcare Americas Corporation's product category is Medical Imaging Equipment. Its primary akta.pro industry code is HLAHABAI, Imaging Informatics & Workflow (PACS/RIS/VNA), with a secondary code of HLAHABAA, X-ray & Fluoroscopy Systems. Its NAICS code is 334510 and its SIC code is 3841.